Thomas Prindle
Overview
Explore the profile of Thomas Prindle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sampah M, Moore H, Ahmad R, Duess J, Lu P, Lopez C, et al.
Nat Commun
. 2024 Oct;
15(1):8613.
PMID: 39375337
Short bowel syndrome (SBS) leads to severe morbidity and mortality. Intestinal adaptation is crucial in improving outcomes. To understand the human gene pathways associated with adaptation, we perform single-cell transcriptomic...
2.
Zhang A, Sodhi C, Wang M, Shores D, Fulton W, Prindle T, et al.
Cell Mol Gastroenterol Hepatol
. 2020 Apr;
10(2):309-326.
PMID: 32330729
Background & Aims: In short-bowel syndrome (SBS), inadequate intestinal adaptation is responsible for the majority of complications, including sepsis, liver failure, and death. In this study, we sought to further...
3.
Sodhi C, Fulton W, Good M, Vurma M, Das T, Lai C, et al.
Br J Nutr
. 2018 Sep;
120(6):665-680.
PMID: 30176959
Necrotising enterocolitis (NEC) is a devastating disease that typically affects formula-fed premature infants, suggesting that dietary components may influence disease pathogenesis. TAG are the major fat components of infant formula,...
4.
Sodhi C, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton W, Wang S, et al.
Am J Physiol Lung Cell Mol Physiol
. 2017 Sep;
314(1):L17-L31.
PMID: 28935640
Angiotensin-converting enzyme 2 (ACE2) is a terminal carboxypeptidase with important functions in the renin-angiotensin system and plays a critical role in inflammatory lung diseases. ACE2 cleaves single-terminal residues from several...
5.
Good M, Sodhi C, Yamaguchi Y, Jia H, Lu P, Fulton W, et al.
Br J Nutr
. 2016 Sep;
116(7):1175-1187.
PMID: 27609061
Necrotising enterocolitis (NEC) is a common disease in premature infants characterised by intestinal ischaemia and necrosis. The only effective preventative strategy against NEC is the administration of breast milk, although...
6.
Yazji I, Sodhi C, Lee E, Good M, Egan C, Afrazi A, et al.
Proc Natl Acad Sci U S A
. 2013 May;
110(23):9451-6.
PMID: 23650378
Necrotizing enterocolitis (NEC) is a devastating disease of premature infants characterized by severe intestinal necrosis and for which breast milk represents the most effective protective strategy. Previous studies have revealed...
7.
Neal M, Sodhi C, Dyer M, Craig B, Good M, Jia H, et al.
J Immunol
. 2013 Mar;
190(7):3541-51.
PMID: 23455503
Necrotizing enterocolitis (NEC) develops in response to elevated TLR4 signaling in the newborn intestinal epithelium and is characterized by TLR4-mediated inhibition of enterocyte migration and reduced mucosal healing. The downstream...
8.
Good M, Siggers R, Sodhi C, Afrazi A, Alkhudari F, Egan C, et al.
Proc Natl Acad Sci U S A
. 2012 Jun;
109(28):11330-5.
PMID: 22733781
The fetal intestinal mucosa is characterized by elevated Toll-like receptor 4 (TLR4) expression, which can lead to the development of necrotizing enterocolitis (NEC)--a devastating inflammatory disease of the premature intestine--upon...
9.
Afrazi A, Sodhi C, Good M, Jia H, Siggers R, Yazji I, et al.
J Immunol
. 2012 Mar;
188(9):4543-57.
PMID: 22461698
Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal-related mortality in premature infants, and it develops under conditions of exaggerated TLR4 signaling in the newborn intestinal epithelium. Because NEC does...
10.
Sodhi C, Levy R, Gill R, Neal M, Richardson W, Branca M, et al.
Am J Physiol Gastrointest Liver Physiol
. 2011 Jan;
300(5):G862-73.
PMID: 21233273
Intestinal mucosal injury occurs after remote trauma although the mechanisms that sense remote injury and lead to intestinal epithelial disruption remain incompletely understood. We now hypothesize that Toll-like receptor 4...